Variant report
Variant | esv2762561 |
---|---|
Chromosome Location | chr5:154403211-154408886 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:200)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr5:154407625-154407940 | HepG2 | liver: | n/a | n/a |
2 | ATF2 | chr5:154403541-154404042 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | ATF2 | chr5:154403546-154404022 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | BACH1 | chr5:154403740-154404035 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | BCL3 | chr5:154403779-154404000 | GM12878 | blood: | n/a | n/a |
6 | CTCF | chr5:154407530-154407905 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | CTCF | chr5:154407673-154407915 | HUVEC | blood vessel: | n/a | n/a |
8 | CTCF | chr5:154407736-154407832 | Fibrobl | skin: | n/a | n/a |
9 | CTCF | chr5:154407575-154407867 | A549 | lung: | n/a | n/a |
10 | CTCF | chr5:154407720-154407870 | GM12875 | blood: | n/a | n/a |
11 | CTCF | chr5:154407760-154407910 | HCFaa | heart: | n/a | n/a |
12 | CTCF | chr5:154407680-154407830 | HEEpiC | esophagus: | n/a | n/a |
13 | CTCF | chr5:154407585-154407959 | A549 | lung: | n/a | n/a |
14 | CTCF | chr5:154407752-154407813 | Spleen_OC | spleen: | n/a | n/a |
15 | CTCF | chr5:154407700-154407850 | HMF | breast: | n/a | n/a |
16 | CTCF | chr5:154407760-154407910 | A549 | lung: | n/a | n/a |
17 | CTCF | chr5:154407660-154407810 | Caco-2 | colon: | n/a | n/a |
18 | CTCF | chr5:154407720-154407870 | HPAF | blood vessel: | n/a | n/a |
19 | CTCF | chr5:154407685-154407890 | Hela-S3 | cervix: | n/a | n/a |
20 | CTCF | chr5:154407645-154407876 | A549 | lung: | n/a | n/a |
21 | CTCF | chr5:154407489-154408074 | HCT-116 | colon: | n/a | n/a |
22 | CTCF | chr5:154407700-154407850 | GM12871 | blood: | n/a | n/a |
23 | CTCF | chr5:154407712-154407861 | GM13977 | blood: | n/a | n/a |
24 | CTCF | chr5:154407680-154407830 | Hela-S3 | cervix: | n/a | n/a |
25 | CTCF | chr5:154407700-154407850 | RPTEC | kidney: | n/a | n/a |
26 | CTCF | chr5:154407711-154407849 | Medullo | brain: | n/a | n/a |
27 | CTCF | chr5:154407682-154407831 | GM19240 | blood: | n/a | n/a |
28 | CTCF | chr5:154407720-154407870 | HFF | foreskin: | n/a | n/a |
29 | CTCF | chr5:154407680-154407830 | AG04449 | skin: | n/a | n/a |
30 | CTCF | chr5:154407683-154407825 | GM19238 | blood: | n/a | n/a |
31 | CTCF | chr5:154407664-154407922 | LNCaP | prostate: | n/a | n/a |
32 | CTCF | chr5:154407740-154407890 | AG09309 | skin: | n/a | n/a |
33 | CTCF | chr5:154407501-154408104 | A549 | lung: | n/a | n/a |
34 | CTCF | chr5:154407693-154407837 | Gliobla | brain: | n/a | n/a |
35 | CTCF | chr5:154403663-154403687 | GM20000 | blood: | n/a | n/a |
36 | CTCF | chr5:154407720-154407870 | GM12878 | blood: | n/a | n/a |
37 | CTCF | chr5:154407627-154407972 | K562 | blood: | n/a | n/a |
38 | CTCF | chr5:154407667-154407911 | GM12878 | blood: | n/a | n/a |
39 | CTCF | chr5:154407680-154407830 | HUVEC | blood vessel: | n/a | n/a |
40 | CTCF | chr5:154407640-154407790 | HCT-116 | colon: | n/a | n/a |
41 | CTCF | chr5:154407721-154407805 | Kidney_OC | kidney: | n/a | n/a |
42 | CTCF | chr5:154407700-154407850 | GM12867 | blood: | n/a | n/a |
43 | CTCF | chr5:154407715-154407840 | GM19239 | blood: | n/a | n/a |
44 | CTCF | chr5:154407700-154407850 | HCM | heart: | n/a | n/a |
45 | CTCF | chr5:154407665-154407888 | MCF-7 | breast: | n/a | n/a |
46 | CTCF | chr5:154407700-154407850 | GM12864 | blood: | n/a | n/a |
47 | CTCF | chr5:154407720-154407870 | HBMEC | blood vessel: | n/a | n/a |
48 | CTCF | chr5:154407660-154407810 | GM12870 | blood: | n/a | n/a |
49 | CTCF | chr5:154407700-154407850 | HA-sp | spinal cord: | n/a | n/a |
50 | CTCF | chr5:154407620-154407770 | GM12872 | blood: | n/a | n/a |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:154350796..154352485-chr5:154407366..154409300,2 | MCF-7 | breast: | |
2 | chr5:154325163..154325827-chr5:154407312..154407816,2 | MCF-7 | breast: | |
3 | chr5:154346758..154347900-chr5:154407299..154408191,5 | MCF-7 | breast: | |
4 | chr5:154351777..154353155-chr5:154407250..154408188,7 | MCF-7 | breast: | |
5 | chr5:154403482..154404265-chr5:154448109..154448989,2 | MCF-7 | breast: | |
6 | chr5:154351810..154352823-chr5:154407320..154408737,6 | MCF-7 | breast: | |
7 | chr5:154402654..154405325-chr5:154405571..154408812,3 | MCF-7 | breast: | |
8 | chr5:154347004..154347710-chr5:154407157..154407900,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000221131 | TF binding region |
ENSG00000221131 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9324797 | chr5:154403211-154403212 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs9324798 | chr5:154403223-154403224 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs189817487 | chr5:154403337-154403338 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs77278123 | chr5:154403351-154403352 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs75734829 | chr5:154403352-154403353 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs286618 | chr5:154403396-154403397 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs182831920 | chr5:154403432-154403433 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559229641 | chr5:154403457-154403458 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569446158 | chr5:154403469-154403470 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538492144 | chr5:154403470-154403471 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556687856 | chr5:154403487-154403488 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564116543 | chr5:154403503-154403504 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540591102 | chr5:154403575-154403576 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573274344 | chr5:154403599-154403600 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs6873298 | chr5:154403613-154403614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552636875 | chr5:154403647-154403648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144391178 | chr5:154403648-154403649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555774047 | chr5:154403660-154403661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544875443 | chr5:154403670-154403671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs55935891 | chr5:154403694-154403695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186506306 | chr5:154403695-154403696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544446033 | chr5:154403803-154403804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561285532 | chr5:154403832-154403833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530078810 | chr5:154403854-154403855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs6893162 | chr5:154403877-154403878 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs145148460 | chr5:154403912-154403913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs191251338 | chr5:154403927-154403928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs138392123 | chr5:154404005-154404006 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569387772 | chr5:154404051-154404052 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148813762 | chr5:154404097-154404098 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183431243 | chr5:154404106-154404107 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566960180 | chr5:154404149-154404150 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7736342 | chr5:154404176-154404177 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs143500847 | chr5:154404208-154404209 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188536697 | chr5:154404233-154404234 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534219789 | chr5:154404245-154404246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs548770425 | chr5:154404251-154404252 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192105267 | chr5:154404329-154404330 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73807230 | chr5:154404335-154404336 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs575365095 | chr5:154404388-154404389 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs544192071 | chr5:154404393-154404394 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs148007568 | chr5:154404447-154404448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7718551 | chr5:154404449-154404450 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs540627143 | chr5:154404478-154404479 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs7736564 | chr5:154404495-154404496 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs375477096 | chr5:154404524-154404525 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs143661976 | chr5:154404545-154404546 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs147186354 | chr5:154404554-154404555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73282576 | chr5:154404581-154404582 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs531918809 | chr5:154404589-154404590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Deafness | 19353646 | CNVD |
Developmental delay | 19353646 | CNVD |
dysmorphism | 19353646 | CNVD |
feeding difficulties | 19353646 | CNVD |
strabismus | 19353646 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Epilepsy | 20502679 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:154399600-154403600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
2 | chr5:154399600-154403600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr5:154402800-154404000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
4 | chr5:154402800-154404600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr5:154403000-154404000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr5:154403200-154403400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr5:154403200-154403600 | Weak transcription | H9 Cell Line | embryonic stem cell |
8 | chr5:154403200-154404600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr5:154403400-154403800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr5:154403400-154404000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr5:154403600-154404000 | Enhancers | H9 Cell Line | embryonic stem cell |
12 | chr5:154403600-154404000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr5:154403600-154404000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
14 | chr5:154403600-154404200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr5:154404000-154404200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr5:154404000-154407400 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
17 | chr5:154404000-154413400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
18 | chr5:154404600-154407400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
19 | chr5:154405200-154406000 | Enhancers | Fetal Heart | heart |
20 | chr5:154407400-154407800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
21 | chr5:154407400-154407800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
22 | chr5:154407400-154407800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |